# Low PD-1 Expression in Cytotoxic CD8+ Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/low-pd-1-expression-in-cytotoxic-cd8-tumor-infiltrating-lymphocytes-confers-an/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Giulia Mazzaschi,Denise Madeddu,Angela Falco,Giovanni Bocchialini,Matteo Goldoni,Francesco Sogni,G Armani,Costanza Annamaria Lagrasta,Bruno Lorusso,Chiara Mangiaracina,Rocchina Vilella,Caterina Frati,Roberta Alfieri,Luca Ampollini,Michele Veneziani,Enrico Maria Silini,Andrea Ardizzoni,Konrad Urbanek,Franco Aversa,Federico Quaini,Marcello Tiseo |
| Citations | 263 |
| DOI | 10.1158/1078-0432.ccr-17-2156 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2766425839 |
| PMID | 29074606 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Enrico Maria Silini](https://scholariq.org/researchers/enrico-maria-silini/)
- [Roberta Alfieri](https://scholariq.org/researchers/roberta-alfieri/)
- [Luca Ampollini](https://scholariq.org/researchers/luca-ampollini/)
- [Marcello Tiseo](https://scholariq.org/researchers/marcello-tiseo/)

## Paper journal

- [Clinical Cancer Research](https://scholariq.org/journals/clinical-cancer-research/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.